Send to

Choose Destination
See comment in PubMed Commons below
IEEE Trans Nanobioscience. 2013 Jun;12(2):65-8. doi: 10.1109/TNB.2013.2240009. Epub 2013 Feb 6.

Experimental study on low-detection limit for immunomagnetic reduction assays by manipulating reagent entities.

Author information

MagQu Co., Ltd., Sindian Dis., New Taipei City 231, Taiwan.


The low limit of detection (LLD) plays an important role in biomolecular assays, especially for early-stage assays. Biomolecular detections usually involve the use of two main elements: a reagent and an analyzer, which both greatly contribute to the LLD. In this work, the relationships among the LLD and reagent-related factors are investigated. The to-be-detected biomolecule is c-reactive protein (CRP) as an example. The assay method is immunomagnetic reduction (IMR). The components of reagent are Fe(3)O(4) magnetic nanoparticles bio-functionalized with antibodies against CRP, dispersed in pH-7.4 phosphate buffered saline solution. Several key factors of the reagent, such as particle concentration, volume ratio of reagent to sample, and particle size, are manipulated to optimize the LLD of detecting CRP.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for IEEE Engineering in Medicine and Biology Society
    Loading ...
    Support Center